Efficacy of the nootropic supplement Mind Lab Pro on memory in adults: Double blind, placebo-controlled study.

What Was Tested

This randomized controlled trial looks at Copper (Supplement).

Auditory, visual, visual working memory, immediate and delayed recall (DR) were assessed.

Who Took Part

According to the abstract, 49 individuals were involved.

The age groups tagged for this paper are teenagers, young adults, adults and middle-aged adults.

A total of 49 healthy individuals completed the study with 36 in the experimental group and 13 in the control group.

Participants ranged between 20 and 68 years with a mean age of 31.4 ± 14.4 years.

How the Study Was Run

In design terms this was a randomized, double-blind and placebo-controlled study.

Random assignment meant chance, not the researchers, decided who got Copper (Supplement) and who got the comparison, which limits bias.

As a double-blind Copper (Supplement) study, the assignments were hidden from both participants and investigators until the end.

A placebo (an inactive look-alike) gave the Copper (Supplement) group a baseline to be compared against.

The study employed a pseudo randomised, double blinded, placebo-controlled design.

All participants completed the Wechsler Memory Scale Fourth UK Edition (WSM-IV UK).

What Was Measured

PubMed files the paper under topics including Nootropic Agents, Memory, Short-Term, Memory Disorders and Dietary Supplements.

The authors tagged it with the keywords Mind Lab Pro, WMS-IV UK, nootropics and recall.

What This Means in Plain Language

The paper is a randomized, double-blind and placebo-controlled study of Copper (Supplement) in 49 individuals.

The abstract goes on to report its results in about 3 sentences; this page does not restate them, so read the paper for the findings and their limits.

The publication is from 2023 (Human psychopharmacology), a journal based in England.

More context: the Copper (Supplement) compound page, all human trials.